The Photocure share price has been increasing steadily even in the face of short sellers thas has been adding to their positions in Photocure stock for three weeks straight. With the stock now trading above the last top, longs will be hoping to see a short squeeze effect in the the price development. Recent 50SMA / 200SMA golden cross. Top 20 ownership...
Added this very promising swedish company to my watch list. Bit late to this party, but looking to buy if the usual sell the news shenanigans occur. Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments. Biovica’s assay DiviTum® measure cell proliferation by detecting a biomarker in the blood stream. The...
With the Hindenburg short accusation report against Nikola, the price of the NEL stock has come under pressure, indicating a possible double top pattern and putting the subsidiary offering in doubt. The stock need to protect the last major support level at around 17.5, or the clearly visible gap in the volume profile will come into play as large amount of recent...
Episurf Medical is a Swedish medical technology company offering personalised solutions for cartilage lesions in the knee joint. Capital Markets day will be streamed live at Redeye, Tuesday September 15, 2020 at 13:00 CEST – 16:00 CEST. Twitter handles recommended to follow for this stock: Episurf - corporate account palryfors - CEO ramlars77 - analyst
Recent oversubscribed equity offerings done at 76 and 65,5 NOK after repurchasing global Hexvix ownership from Ipsen now securely in the money. Recent newsflow: 13.08.2020 Photocure appoints Genotests as exclusive partner for Hexvix in Chile 08.07.2020 Photocure's partner Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for...
BTC steadily consolidating gains above crucial 10500 level
photocure.com www.avanza.se
Norne securities july 31st: BUY 150 NOK ABG Sundal Collier july 1st: BUY 120 NOK Edison may 13th: BUY 109 NOK
OSE35GI Health Care / Helsevern Ticker - Name - Marketcap in Billion NOK MEDI - Medistim 4,2 BGBIO - BerGenBio 3 AZT - ArcticZymes Technologies 2,6 PHO - Photocure 2,1 PCIB - PCI Biotech Holding 2 COV - ContextVision 1,9 NANO - Nordic Nanovector 1,8 ULTIMO - Ultimovacs 1,5 CARA - Carasent 0,96 VISTIN - Vistin Pharma 0,65 TRVX - Targovax 0,59 NAVA - Navamedic 0,32
In july analysts predicted up to 100% upside in $PHO stock. Still significant amount of short positions reported.
Bitcoin Group SE is the owner of Bitcoin.de, a large German Crypto exchange. Stock is not very liquid, but is slowly following Bitcoin in a bullish move
Q2 presentation scheduled for august 19th
On the back of Bitcoin and Ethereum breaking out from the crypto bear market, the stock of Bitcoin Group SE is making a similar promising move. Bitcoin Group SE based in Germany is the company behind Bitcoin.de, one of the largest Bitcoin exchanges in Europe. Bitcoin.de entered into a strategic partnership with Fidor Bank AG in Munich, allowing users to process...
Nordic Nanovector stock has been consolidating upon positive news about FDA Fast Track Status for Betalutin and amended patient eligibility criteria in the PARADIGME clinical trial, and looks set to draw a golden cross for the first time since the pre ASH rally of 2018. Entrys should be made with keen eyes on risk management, but it is nice to see some good...
Bitcoin Group SE is among others the company behind Bitcoin.de, a large european Bitcoin marketplace. The stock correlates fairly well with the Bitcoin price, and gives an attractive way to get exposure to crypto price movements in your brokerage account.
"Covid-19 potential road to market"
SOTKAMO SILVER HIGHLIGHTS OF THE FIRST QUARTER 2020 Press release: Stockholm, 29 May 2020 9.45 CET Net sales was 91 MSEK (0) EBITDA was 8 MSEK (-11) EBIT was -11 MSEK (-14) Earnings per share was 0.03 SEK (-0.12) Cash and cash equivalents were 10 MSEK (33) Investments were 9 MSEK (88) The production was about 391 000 ounces silver, 998 ounces gold, 462 tonnes...
Closely monitoring this area of support, though still too early to make a call